31. The impact of SARS-CoV-2 primary vaccination in a cohort of patients hospitalized for acute COVID-19 during Delta variant predominanceDaša Stupica, Stefan Collinet-Adler, Nataša Kejžar, Zala Jagodic, Mario Poljak, Mirijam Nahtigal Klevišar, 2022, izvirni znanstveni članek Ključne besede: COVID-19 vaccine, vaccine breakthrough, vaccination impact, COVID-19 outcome Celotno besedilo (datoteka, 709,47 KB) Gradivo ima več datotek! Več... |
32. Comparison of the clinical and analytical performance of Alinity m HR HPV and cobas 4800 HPV assays in a population-based screening settingAnja Oštrbenk Valenčak, Alexander Bertram, Arndt Gröning, Mario Poljak, 2021, izvirni znanstveni članek Ključne besede: cervical cancer, human papillomavirus, screening, validation, alinity, cobas Celotno besedilo (datoteka, 410,13 KB) Gradivo ima več datotek! Več... |
|
34. Real-life head-to-head comparison of performance of two high-throughput automated assays for the detection of SARS-CoV-2 RNA in nasopharyngeal swabsRok Kogoj, Petra Kmetič, Anja Oštrbenk Valenčak, Kristina Fujs Komloš, Katja Seme, Martin Sagadin, Miša Korva, Mario Poljak, 2021, izvirni znanstveni članek Ključne besede: SARS-CoV2, molecular analyzer, Abbott's Alinity m Celotno besedilo (datoteka, 411,54 KB) Gradivo ima več datotek! Več... |
35. HIV-1 unique recombinant forms identified in Slovenia and their characterization by near full-length genome sequencingMaja M. Lunar, Jana Mlakar, Tomaž Mark Zorec, Mario Poljak, 2020, izvirni znanstveni članek Ključne besede: molecular epidemiology, HIV-1, subtype, unique recombinant form, near full-length genome, next-generation sequencing, surveillance Celotno besedilo (datoteka, 2,65 MB) Gradivo ima več datotek! Več... |
36. Head-to-head comparison of two rapid high-throughput automated electrochemiluminescence immunoassays targeting total antibodies to the SARS-CoV-2 nucleoprotein and spike protein receptor binding domainMario Poljak, Anja Oštrbenk Valenčak, Tina Štamol, Katja Seme, 2021, izvirni znanstveni članek Ključne besede: SARS-CoV-2, immunoassay, antibody, COVID-19, electrochemiluminescence Celotno besedilo (datoteka, 361,34 KB) Gradivo ima več datotek! Več... |
37. Molecular epidemiology and characterization of enteroviruses detected in cerebrospinal fluid and respiratory samples in Slovenia, 2014–2023Nataša Berginc, Maja M. Lunar, Nina Šramel, Mario Poljak, 2024, izvirni znanstveni članek Ključne besede: cerebrospinal fluid, CSF, enteroviruses, respiratory samples, surveillance, typing Celotno besedilo (datoteka, 6,09 MB) Gradivo ima več datotek! Več... |
38. New insights into the evolutionary and genomic landscape of molluscum contagiosum virus (MCV) based on nine MCV1 and six MCV2 complete genome sequencesTomaž Mark Zorec, Denis Kutnjak, Lea Hošnjak, Blanka Kušar, Katarina Trčko, Boštjan Kocjan, Yu Li, Miljenko Križmarić, Jovan Miljković, Maja Ravnikar, Mario Poljak, 2018, izvirni znanstveni članek Ključne besede: molluscum contagiosum virus, complete genome, recombination, immune evasion, evolution, genetic landscape Celotno besedilo (datoteka, 3,38 MB) Gradivo ima več datotek! Več... |
39. Clinical evaluation of INNO-LiPA HPV Genotyping EXTRA II assay using the VALGENT frameworkLan Xu, Elizaveta Padalko, Anja Oštrbenk Valenčak, Mario Poljak, Marc Arbyn, 2018, izvirni znanstveni članek Ključne besede: INNO-LiPA, VALGENT, HPV genotyping, cervical cancer, human papillomavirus, clinical validation, Hybrid Capture 2, Linear Array, HPV, INNO - LiPA HPV genotyping EXTRA II Celotno besedilo (datoteka, 238,72 KB) Gradivo ima več datotek! Več... |
40. Commercially available molecular tests for human papillomavirusesMario Poljak, Anja Oštrbenk Valenčak, G. Gimpelj Domjanič, Lan Xu, Marc Arbyn, 2020, pregledni znanstveni članek Ključne besede: cervical cancer, human papillomaviruses, commercial tests, HPV, screening Celotno besedilo (datoteka, 901,18 KB) Gradivo ima več datotek! Več... |